Billable / Specific Code
ICD-10-CM T80.810 is the diagnosis code for Extravasation of vesicant antineoplastic chemotherapy. This code falls under the section "Complications of surgical and medical care, not elsewhere classified" within Chapter 19 — Injury, poisoning and certain other consequences of external causes (S00-T88). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where T80.810 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, T80.810 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
T80.810 is the ICD-10-CM diagnosis code for "Extravasation of vesicant antineoplastic chemotherapy". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of T80.810 is T80.81 ("Extravasation of vesicant agent"). T80.810 provides a more specific classification within this category.
T80.810 is located in Section T80-T88 — "Complications of surgical and medical care, not elsewhere classified" within Chapter 19 of the ICD-10-CM Tabular List.
Use T80.810 when the patients documented diagnosis matches "Extravasation of vesicant antineoplastic chemotherapy" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Extravasation of vesicant antineoplastic chemotherapy is T80.810.
Yes, T80.810 can be used as a primary diagnosis code since it is billable and specific.
T80.810 is in Chapter 19 of the ICD-10-CM Tabular List.
Yes, T80.810 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.